An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma

An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma

We investigated the local immune status and its prognostic value in lung adenocarcinoma. In total, 513 lung adenocarcinoma samples from TCGA and ImmPort databases were collected and analyzed. The R package coxph was employed to mine immune-related genes that were significant prognostic indicators us...

Full description

Bibliographic Details
Main Authors:	Minghui Zhang, Kaibin Zhu, Haihong Pu, Zhuozhong Wang, Hongli Zhao, Jinfeng Zhang, Yan Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-12-01
Series:	Frontiers in Oncology
Subjects:	hierarchal clustering immunophenotypes lung adenocarcinoma patient prognosis riskscore
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2019.01314/full

Similar Items

Identification of an Immune-Related Long Noncoding RNA Pairs Model to Predict Survival and Immune Features in Gastric Cancer
by: Shenglei Song, et al.
Published: (2021-09-01)

Identification of glioblastoma immune subtypes and immune landscape based on a large cohort
by: Huiyuan Zhang, et al.
Published: (2021-08-01)

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
by: Dina Guo, et al.
Published: (2020-03-01)

Four-miRNA signature as a prognostic tool for lung adenocarcinoma
by: Lin Y, et al.
Published: (2017-12-01)

Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas
by: Mark Menor, et al.
Published: (2019-01-01)

Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma
by: Pengcheng Zhou, et al.
Published: (2021-07-01)

Lipid metabolism gene-wide profile and survival signature of lung adenocarcinoma
by: Jinyou Li, et al.
Published: (2020-10-01)

Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma
by: Fujun Zhang, et al.
Published: (2020-10-01)

An expression signature model to predict lung adenocarcinoma-specific survival
by: Shi X, et al.
Published: (2018-09-01)

A Prognostic Nomogram Combining Immune-Related Gene Signature and Clinical Factors Predicts Survival in Patients With Lung Adenocarcinoma
by: Congkuan Song, et al.
Published: (2020-08-01)

An individualized immune prognostic signature in lung adenocarcinoma
by: Liangdong Sun, et al.
Published: (2020-05-01)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
by: Yang Cheng, et al.
Published: (2021-06-01)

Signature identification of relapse-related overall survival of early lung adenocarcinoma after radical surgery
by: Peng Han, et al.
Published: (2021-08-01)

Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma
by: Xiaodong Yang, et al.
Published: (2019-07-01)

High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma
by: Feng Jiang, et al.
Published: (2021-07-01)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
by: Guomin Wu, et al.
Published: (2021-07-01)

Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis
by: Ziyuan Ren, et al.
Published: (2021-08-01)

Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients
by: Jun Shao, et al.
Published: (2021-01-01)

Comprehensive Analysis of a Nine-Gene Signature Related to Tumor Microenvironment in Lung Adenocarcinoma
by: Haihui Zhong, et al.
Published: (2021-09-01)

A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma
by: Qiujuan Huang, et al.
Published: (2021-05-01)

Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma
by: Lulu He, et al.
Published: (2020-12-01)

Unique metastasis‐associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma
by: Xiaoshi Zhang, et al.
Published: (2020-03-01)

Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients
by: Jingjing Cai, et al.
Published: (2021-08-01)

Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method
by: Qidong Cai, et al.
Published: (2020-10-01)

Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients
by: Zihuan Zhao, et al.
Published: (2020-05-01)

HLA-G Expression in Lung Adenocarcinoma Tissues and Its Relationship with Prognosis
by: ZHANG Wenlong, et al.
Published: (2018-08-01)

The characteristics and nomogram for primary lung papillary adenocarcinoma
by: Zhang Yuqian, et al.
Published: (2020-02-01)

Expression of ASPM in Lung Adenocarcinoma and Its Relationship with Development and Prognosis
by: Junjie WANG, et al.
Published: (2020-01-01)

The correlation of WDR76 expression with survival outcomes and immune infiltrates in lung adenocarcinoma
by: Likui Fang, et al.
Published: (2021-10-01)

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
by: Qian Song, et al.
Published: (2019-03-01)

Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma
by: Cheng Yue, et al.
Published: (2019-11-01)

A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma
by: Xuelong Wang, et al.
Published: (2021-07-01)

Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma
by: Lan Mu, et al.
Published: (2021-03-01)

Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
by: Pancheng Wu, et al.
Published: (2020-10-01)

The Significance of Serum Carcinoembryonic Antigen in Lung Adenocarcinoma
by: Jae Jun Kim, et al.
Published: (2015-10-01)

High-grade Fetal Adenocarcinoma of the Lung: A Case Report
by: Chuan HUANG, et al.
Published: (2019-03-01)

Mast cell‐based molecular subtypes and signature associated with clinical outcome in early‐stage lung adenocarcinoma
by: Xuanwen Bao, et al.
Published: (2020-05-01)

Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas
by: Sijin Sun, et al.
Published: (2021-02-01)

Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma
by: Zhaodong Li, et al.
Published: (2020-11-01)

Systemic Inflammation Response Index (SIRI) Independently Predicts Survival in Advanced Lung Adenocarcinoma Patients Treated with First-Generation EGFR-TKIs
by: Jiang S, et al.
Published: (2021-02-01)